Clinical trials: Relapsed/Refractory Multiple Myeloma (MM)

Multiple Myeloma

A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

• Terminated
• Age: 18 years and older
• Phase 2
• Results posted

This was an open-label, multicenter study designed to evaluate the safety and preliminary efficacy of venetoclax combined with pomalidomide and dexamethasone in participants with relapsed or refractory (R/R) multiple myeloma (MM)…

Trial name

NCT03567616

Testing

Venetoclax, Pomalidomide, Dexamethasone

Where

11 sites in United States, Spain and 1 more

Volunteers

8 people

Sponsor

AbbVie